LONDON — A new statistical model developed by scientists at the Francis Crick Institute revealed 27 novel genes thought to prevent cancer from forming, in an analysis of over 2000 tumors across 12 human cancer types. The findings could help create new cancer treatments that target these genes, and open…...
The National Foundation for Cancer Research, led by Chairman Joseph F. Franlin and President Sujuan Ba, recruited a delegation of eight U.S. cancer technology start-ups for a successful exploratory mission to China. The companies—ArrayBio, Eutropics, Immix Biopharma, InterLeukin Therapeutics, International Cancer Impact Fund, InVaMet Therapeutics, Nonpareil Biotechnologies and Stromatis Pharma—were…...
As the tidal wave of pink paraphernalia synonymous with October ebbs, and our thoughts turn to turkey, football and autumn foliage in full Technicolor array; it’s important to keep in mind that preventing breast cancer is a year-round affair. Vigilance is mandatory; that is if preventing and detecting the onset…...
Many common cancer treatments and surgeries are invasive and have uncomfortable or painful side-effects which make movement and participation in even the most basic of activities a challenge. Patients are traditionally told to take it easy after being diagnosed or undergoing surgery and treatments. However, a change in school of…...
CLEVELAND, OH — Two studies conducted by the Cleveland Clinic revealed how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that men who inherit this variant would benefit from a personalized…...
All consuming, unforgiving, destructive: adjectives easily attributable to the symptoms, treatments, diagnosis and battle with cancer. These descriptors also paint an accurate rendering of the infernos into which American fire fighters, America’s Bravest, venture unflinchingly as they perform their duty. In a recent exposé, experts uncovered a disturbing trend which…...
In the past two months, the FDA has approved a revolutionary new form of immunotherapy, called chimeric antigen receptor (CAR) T cell therapy, for two blood cancers: B cell acute lymphoblastic leukemia (ALL) in August, 2017 and now on October 18th, for aggressive diffuse large B cell lymphoma (DLBCL), a…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
